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Herlitzjunctional epidermolysis bullosa is an autoso-
mal recessive disorder characte rized by generalized 
blistering at the lamina Iucida of the cutaneous base-
ment me1nbrane. The monoclonal antibody GB3 has 
been used as a diagnostic probe because of its lack of 
reactivity in patient skin. The antigen recognized 
by GB3 has been identified as laminin-5, a glycopro-
tein consisting of three subunits (a3, {33 and y2). To 
identify the laminin-5 protein chain that contains the 
epitope recognized by GB3 and to determine if chain 
assembly is required for antibody recognition, we 
expressed a y2 protein constructed from a full-length 
y2 eDNA. Radioimmunoprecipitation of the culture 
medium from 293 cells revealed that both GB3 and 
anti-y2 polyclonal antibodies were capable of directly 
precipitating recombinant y2 without coprecipita-
unction al epide rmo lysis bull osa QEB) is an autosomal rc-
cessi.ve disorder characteri zed by generalized bliste r forma -
tio n at the level of the lamina Iucida within the dermal-
epidermal basem ent m embrane [1 ). J EB ca n be separated 
into two ca tegories, the H erli tz variety (HJ EB) o r leta li s 
type is the m o re severe, often resulting in death during 
in fa ncy, and the non-Herlj tz o r gene ralized non-H erlitz 
fo rm s are non-l e tha l. Ultrastructural studies of HJ EB skin have 
demonstrated e ith er absent o r grea tly reduced anchoring filam ents, 
structures that arc be lieved to prov ide the bridge between the 
h em idesm osom c and lamina dcnsa regio n of the basem en t m em-
bran e [2) . 
[mmunorcagcn ts ha ve been develo ped to allow rapid diagnosis 
of J EB. O ne of the most use ful has been monoclonal antibody 
(MoAb) GB3, w hich labe ls the basem ent membrane in indirect 
flu orescence assays of normal skin, but its reactivity is reduced o r 
absent within the basemen t m embrane of HJEB patients [3 ,4). T he 
specifi c lack of immuno histochemica l sta ining w ith GB3 serves as a 
basis for the di agnosis of this disease in bo th fu ll-term and prenata l 
patients [5 ,6). 
T he antigen recognized by GB3, orig inally te rmed ni cein by 
V c rrando and O rtonnc, has been identifi ed as a heterotrimeric 
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tion of other proteins. In immunodepletion experi-
ments, each antibody removed most of the protein 
that was reactive with the other antibody. The 
epitope recognized by GB3 is present only when the 
complex is in the native conformation because GB3 
reacted only with the non-reduced laminin-5, but not 
the reduced laminin-5 in immunoblots. Moreover 
because GB3 reacted with laminin-5 of SCC25 cell~ 
(y2 in the heterotrimer) but not recombinant y2 in 
293 cells (y2 alone) during indirect immunofluores-
ence staining, this epitope may be dependent upon a 
less stable conformation ofy2. We conclude that GB3 
recognizes the y2 chain of laminin-5 and that the 
epitope is entirely contained in the native form of the 
y2 chain. J Invest Damato/ 105:648-652, 1995 
glycoprotein contammg three nonidentical subunits covalently 
linked by disulfide bonds [7] . T he identica l, or an ex tremely close lv 
re lated, protei n was isolated and ch aracterized by Burgeson and 
co ll eagues, who suggested the name of kalinin 18, 9]. (Recently, a 
new no m enclature for laminin chain s and their isoforms has been 
pro posed [10). According to this system , nicein / ka linin is now 
referred co as laminin-5.) Laminin-5 represen ts an isoform of 
laminin (now ca lled laminin-1 ), a w ell-charactcJ.i zed basement mem-
brane g lycoprotein . T he entire primary sequence of the y2 chain of 
laminin-5 has bee n e lucida ted and the correspondin g gene has been 
mapped to human chromosome 1 q25-31 [11,12] . Like laminin-1. 
laminin-5 consists of three subunit polypeptides, the A, B l , and B2 
ch ains (now termed, a3, (33, and y2). Additionally, as is the case for ' 
laminin-1 , the (33 and y2 chains of laminin-5 associate along tl1e 
long arm with the a3 chain of the m olecule to assume a m odified 
c ru ciate conform ation [1 2). 
Mutations in the y2 chain gene of the GB3-negative H]EB 
patients ha ve recentl y been reported [13 ,14), a finding that would 
seem to suppo rt the notion that GB3 reactiv ity in the basement 
m embrane migh t be dependent upon the y2 chain . Howev er, 
mutations in any of the chains of the heterotrimeric complex could 
affec t the assembly and stability of laminin-5, and therefore simple 
loss of reactivity would no t identify unambiguo usly w luch chain 
conta ins the GB3 epito pe. 
Despite the usefulness of GB3 as a probe fo r HJEB diagnos is, it is 
stiLI unclea r which laminin-5 chain GB3 recognizes, if any, and if 
compl ete heterotrimcr assembly is req uired for antibody recog~u­
t ion. T he epitopc recognized by GB3 may also be specific for natin~ 
or denatured forms o f the protein. Identification of the epitope 
recognized by GB3 is cru cial for the inte rpretation of resul ts of 
0022-202X/95/$09.50 • SSD I0022-202X(95)00335-I • Copyright © 1995 by The Society for In vestigative Dermato logy, Inc. 
648 
VOL. 105, NO. NOVEMBER 1995 
imm unohi stoch e mica l sta inin g of J EB patie nt skin , because if G B 3 
is c h ain sp ecific it may n o t d e tect laminin 5 d efects in oth er ch a ins 
of the h etero trime r. Here, we re port th a t a recombinant y2 pro te in 
(r- ]'2) expressed b y a y2 eD N A transfected into 293 cells is 
specifica lly recognized in its native sta te b y GB3, but tha t the 
1 epitope is lost by de n aturation . 
MATERJALS AND METHODS 
Antibodies MoAb Gl3 3 was obtained commercially fro m Sera-lab (S us-
sex, England). Polyclonal anti-laminin-5 antibody was kindly provided by 
Dr. Peter Marinkovich [8] . A fusion prote in derived fro m a eDNA encoding 
1 the central domain of the y2 protein [1 2] was used to raise anti-y2 antibodies 
in rabbits. T he eDNA clone was subcloned into the Eco JU site ofpGEX-1 At 
, prokaryotic expression vector (Pharmacia). The fusion prote in was prepared 
upon i nductio n and purified according to tnan ufacturcr's instructio ns and 
used as an antigen for immunization of rabbits. 
Const:ruction of Full-Length y2 Protein eDNA in a Eukaryotic 
Expression Vector We constructed a fu ll -length y2 chain eDNA that 
encodes the enti re open read ing frame fi·mn fo ur eD NA clones j1 2]usi ng 
overl apping internal re stri c ti o n endo nuclease sites . This constructio n w:1 s 
placed in a Bluescript vector (Stratagene) and the entire y2 chain eDNA was 
inserted into a eukaryotic expression vector pC PS (DNA Factory. 4 15-
, FASTD NA). The express ion vecto r contains transcriptional control regions 
of th e human cytomegalovirus, including the cytomegalovirus enhancer . 
promoter, and sp li ce donor sequences. The inserted eDNA is fo llowed by 
the polyadenylation site and the transc ription te rminator of the late region 
t of SV 40. T he plasmid was designated pC PSy2 . 
I Cell Culture and Transfection T he squamous ce ll ca rcin oma line, 
SCC-25 (American T ype C ul ture Collecti on C ll:L1628). produces the same 
' Jaminin-5 molecule as produced by normal human keratinocytes [1 5]. 
SCC-25 was cultured in 50'X• Ham's F-1 2 medium . 50% Dulbecco's 
modilied Eagle's medium (D MEM) supplemented with 0.5 iJ.g/ ml hydro-
cortisone and I 0% newborn cal f se rum. T he human embryonal kidney ce ll 
' line , 293 (A n1crican Type C ulture Coll ectio n C ll...L 1573) . was cul tured in 
( DMEM and ·1 0% fe tal bovine se rum . SubconAuent 293 ce lls were trans-
fcc ted with I 0 iJ.g pCPSy2 and 2iJ.g prlSV-Neo plas mid DNA by the 
ca lci utn phosphate co-precipi tation method [1 6]. Two da ys later cell s were 
passaged in a 1:4 ratio and grown in the presence ofG4 18 (200 iJ.g/ml ) until 
cOlonies fo nncd . After iso lation of co lo nies . r-y2-producing clones were 
selected by immunoblo tting of culture medium using anti- y2 antibodies. 
Biosynthetic Labeling Study SubconAuen tl y gro wn 293 ce ll s, r-y2-
express ing 293 cells, and SCC- 25 ce lls we re incubated in methionine- and 
, cystin e - defi cient DMEM for 2 h. and then cultured in defi cient DMEM with 
, 100 J.LCi/ml of protein labe li ng mix (NEN) for 24 h. Medium fract ions were 
processed for immunoprecipitation. rladio immunoprecipitation procedures 
were performed as have been desc ribed f1 5]. In the immunodep lerion 
experiments with GB3 and an ti- y2 protein antibody. each sample was 
cleared of the fi rst antibody-a ntigen complexes by incubation for 1 h with 
anti-rabbit antibody aga rose beads (S igma) foll owed by ceno·ifugation. T he 
supen1atant was then further incubated with the second antibody to 
' deternune the extent to which the target antigen. r-y2. had been removed. 
Indirect Immunofluorescent Staining Cell s were grown fo r 2- 3 d on 
16- well Chamber Slide (Lab-Tek). fixed with 100% methanol for 5 min at 
1 
- 20°C and blocked with blockiug bufl'cr [phosphate-bufl'crcd saline (PBS) 
with 10% goat serum] . Ce lls we re incubated with Gl33, di luted I / 16 in 
blocking buffer. and an ti-y2 antibodies . di lu ted ·1 / 32 in blocking bufFer. T he 
an ti-y2 antibod ies were affin ity puri fied by the y2 subuni t of the immuno-
affi nity-iso lated lamini.n -5 that was elcctrotransfered to nio·oce llulose filters 
according to the method of Verrando ct nl [17]. Goat anti-mouse coupled 
wi th fluoresce in isotltiocyana te (FJTC) (S igma) , di luted l/64 in blocking 
buffe r, and Goat anti-rabb it coupled with Auoresccin iso thiocyanate (S ig-
ma), dil u ted I I 40 in blocking buff'cr. were used as the second antibodies . 
Both incubations were 1 h at room tem perature. 
Other Methods Previously described methods include sodium dodecyl-
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) [1 8]. electro-
phoretic transfer of proteins for immun oblot analysis [1 9], and two dimen-
tional SDS-PAGE [20]. To visualize radioac tively labeled proteins in the 
acrylan1ide ge ls. Auorograp hy was conducted by impregnating the gels with 
Amplify (Amersham) followed by drying and exposure to fi lm. 
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RESULTS 
GBJ and Anti-]'2 Antiserum Immunoprecipitate the Same 
Protein Complexes, Including r-]'2 The sq u am o us cell carci-
n oma cell line SCC-25 is reported to be d erived fi·om kera tinocytes 
and is known to secrete laminin-5 into the culture m edium [15]. 
We u sed this cell line to ch aracterize th e abili ty of MoAb GB3 and 
o ur own anti-y2 antiserum to d etect y2 in immunoprecipita tion 
anal ysis. Metabolica lly rad io labeled SCC- 25- conditio n e d culture 
m edium was immunoprecipitated u sing severa l diffe rent an tib ody 
preparations. Polyclona l anti-lam inin-5 an ti body specifica lly pre-
c ipitated two e lectrophore ti c sp ecies before disulfide b o nd redu c-
tion (Fig 1A, lane 9). T h e sam e two e lectroph o re tic species were 
precipitated by M oAb GB3 and p o lyclon al anti-y2 antibo d y (lanes 7 
and 8) . Under re ducing conditio n s (Fig 1B, lmtes 7, 8, mtd 9), the 
precipitates contained four b ands corresponding to processed a3 
(165 kDa), /33 (145 kDa) , unprocessed y2 (155 kDa), and processed 
y2 protein (lOS kDa) [15]. 
T he sam e antibodies were u sed in immun oprecipitatio n of r-y2 
from the m edium o f stably transfected 293 cell s . A ll precipitates 
sh owed a sing le band of th e sam e size as unprocessed y2 protein 
unde r reducing conditions (Fig 1B, lmtes 4, 5, a11rl 6). 
Under nonreducing conditio n s, the sam e sample sh owed seven 
b ands. We speculate that th ese b ands in non-redu cing conditions 
re present both d e n atu red monomers an d tig htl y fo lde d m o n omers, 
as well as dimers an d o ligom e rs (indicated by has h m arks in Fig 1A, 
ln~~ es 4, 5, a11rl 6). To test th e ide ntities of these b ands further , the 
n o n-red uced sa mpl e lane (Fig 1A, lane -1) was e lectroph oresed in a 
second dime n sion unde r re ducing conditio n s. O nl y a sing le MW 
species correspo nding to the y2 m o n o m er was o b served in each of 
the pos itio ns corresp o nding to the multimers o bserved in the first 
dimension (Fig 1 C) . T h e ab sen ce of oth er ban ds in the second 
dim ensio n e xcludes th e e:>.:iste n ce of he tero-oligom e ri c forms of 
r-y2 and other m o lecul es (Fig 1C). Because 0. 1 M iodoaceta mide 
was included du r ing the extraction procedure to limit n o n-specific 
interactions am o n g protein s, it is unlike ly that th e hig he r-mo lecu-
lar-we ig ht o ligomeric forms were a rtifuctual. T hese data thu s 
suggest tha t the slower migra ting b ands a re indeed multime rs of th e 
y2 m o n o m e r. In terestingly, the o J.i gom e rization of indiv idual 
ch a in s h as also been re ported for th e laminin-1 /31 and y2 chains 
[21 ] . 
Immunodepletion with GBJ and Anti-]'2 Antibody Show 
Recognition of the Same r-y2 Protein To confirm that GB3 
and anti-y2 antibody recognize the sam e protein, we sou ght to 
deple te th e r-y2 fro m the sample m edium using e ither one of the 
antibo d y preparations in a first cycle of immunoprecipitatio n s. T h e 
supernatants o btained after GB3 o r an t i-y2 an tibody immunopre-
c ipitatio n were then treated with a second cycle of immun o precipi-
tation with the remainin g antibody (Fig 2) . T he tite r of our an ti- y2 
an t ibody pre par atio n was high er than t he GB3 antibody ava ilable 
fro m a comme rcia l source . T h erefore, when the an t i-y2 antibody 
was u sed first to de plete the radio lab e led g rowth medium of cells 
pro ducing recombinant y2, Li t tl e detec tab le r-y2 re m ained to b e 
precipitated b y GB3 (Fig 2 , ln~~e A2). An e ig h tfo ld g rea ter volume 
of the lower titer GB3 antibody preparation was necessary to 
d eple te the r-y2 of th e m edium b efo re subsequen t treatment w ith 
the anti-y2 antibo dy fa ile d to precipi tate furth er a substantial 
amount of th e r-y2 (Fig 2 , lane D2). M an y faint lower-mo lecular-
weight b ands are n oted in each lan e that are probably degradation 
products ofr-y2 . In suppo r t of thi s in te rpretatio n, n o reactivity with 
any of the three anti se ra , GB3, an ti-y2, o r anti-laminin-5 were 
o bserved in the m edia ofuntransfected 293 cell s (Fig 1B. ln~~ es t , 2, 
a11 rl 3), indica ting that n o laminin-5 ch a ins are present in 293 cells, 
and that these b ands a re therefore specific for the sing le transfected 
r- y2 c hain. The observation that a sing le recombinant ch ain is 
subj ect to d egradation is not surpri sing, b ecause these ch ains are 
normally assembled in to a h eterotrim er that stabilizes th em from 
degradation . 
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Figure 1. lmmunoprecipitation of recombinant y2 and laminin-5 
h eterotrimer by GB3, anti- y2, and anti-laminin-5 antisera. A, 
con1parative iin inunoprccipitation under non-reducing conditions. Each 
sample was boiled in SDS sample buffer without 2-mercaptoethanol. After 
a 24-h radiolabeling period, conditioned medium fraction of293 cell s (lm1es 
1 to 3), pRKy2-transfected 293 cell s (/niles 4 to 6), and SCC-25 cells (/nil es 
7 to 9) were immunoprecipitated with the fo llowing antibodies: GB3 (/niles 
1, 4. nlld 7), anti-y2 antibody (/niles 2, 5, nlld 8), and anti-laminin-5 antibody 
(/alles 3, 6, alld 9). Proteins were separated on 5% acrylamidl! gel and 
visualized by fluorography . B, compara tive imm unoprecipitation under 
red ucing condi tions. Same samples as Fig l A were boiled in SDS sample 
buffer with 2-mercaptoethanol. C, two-dimensional SDS-PAGE analysis of 
the precipitated recombinant y2 protein. R.ccombinant y2 protein immu-
noprecipitated with GB3 from the conditioned medium after a 24-hour 
radiolabeling period was subjected to two-dimensional SDS-PAGE. Elec-
trophoresis in the first dimension was performed without reduction of 
disulfide bonds; electrophoresis in the second dimension was performed by 
applying the cut gel, infused with 2-mercaptoethanol, to top of a polyacryl-
amide slab. The opell circles denote the origin of gels. The duplicate gels 
under nonreducing and reducing conditions are shown along each dimen-
sio n. 
GB3 Recognizes Only the Heterotrimeric Laminin-5 in 
Immunoblotting In reduced SCC- 25 medium samples, an anti-
laminin-5 antibo dy previo usly characterized as capabl e of recog-
nizing aU processed and unprocessed chains of the laminin- 5 
heterotrim er detected the sam e four bands as shown by immuno -
precipitation (compare Fig 3B, lotte 9 and Fig lB, lntte 9). Anti-y2 
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Figure 2. GB3 and anti y2 antisera both recognize the same 
protein by immunodepletion. To deplete the radiolabeled r-y2 from the 
medium of transfected 293 cells, we used either one of the antibody 
preparations in a first cycle of immunoprecipitations (lau es A -1, B-1. C-1. 
a111l D-1). The supernatants obtained after GB3 or anti-y2 antibody immu-
noprecipi tation were then treated with a second cycle of immunoprecipi-
tation with the remaining antibody (lalles A-2, B-2, C-2, alld D-2). Because 
the titer of the anti-y2 antibody preparation was higher than that of the GB3 
antibody, an eightfold greater volume of GB3 antibody preparation was 
necessary to deplete the r-y2 . At the higher concentrations of GB3 
antibody, subsequent treatment with the anti-y2 antibody fa il ed to precip-
itate a substantial amount of the r-y2 (I aile 02). 
antibo dies recognized bo th unprocessed (155 kDa) and processed 
(lOS kDa) y2 protein (Fig 3B, lntt e 6). Additio nal smaUer bands 
were also o bserved in the m ed ium of transfected 293 ce lls (Fig 3B, 
lane 5) that may represent proteolytic breakdown products of y2. 
GB3 w as unable to recognize an y y2 protein under the same 
reducing conditions (Fig 3B, Iottes 2 nttd 3) but was able to 
recognize the 440-kDa and 400- kDa complexes in non-reduced 
SCC- 25 m edium (Fig 3A, latte 3), as were the anti-y2 and anti-
laminin-5 antibody preparatio ns (Fig 3A, lmres 6 nttd 9). 
E lectrophoresis of r-y2 unde r reducing conditions revealed some 
fas ter-migrating products presumed to represent incorrectly pro-
cessed forms and/or degrad ed products (Fig 3B, lntte 5). Under 
non-reducing conditions, electropho resis of r- y2 was recognized 
(by both anti-y2 and anti-laminin- 5 an tibodies) as a som ewhat 
diffuse band of 155 kDa w ith tightly folded m o nomers migrating 
more quickly (Fig 3A , Iottes 5, 8) . GB3 failed to react with any of 
the protein bands (Fig 3A, /nne 2). 
GB3 Recognizes Only Secreted Heterotrimer by Indirect 
Immunofluorescence Staining lmmunolocalization of lami-
nin-5 and r-y2 detected by GB3 and anti-y2 antiserum in 293 cells 
expressing r-y2 and SCC- 25 ceUs is compare d in Fig 4 . Both 
antibodies were negative for staining of no ntransfected control 293 
cells (Fig 4A,B). Both an tibodies recognized laminin-5 that local-
ized to intercellular bo undaries and the trailing edge of migrating 
SCC-25 cells (Fig 4C,D) . T he anti-y2 antiserum also sh owed 
intracellular granular stainin g on the SCC- 25 cell sample (Fig 4D) 
whereas GB3 did not (Fig 4q, consistent w ith the possibility that 
the antigenic determinant on y2 recognized by GB3 is not formed 
until after assembly and secretion of the completed heterotrimer. 
When an ti-y2 antiserum was used, strong intrace llular granular 
staining was v isible . T here was no extracellular staining (Fig 4F), 
however, consistent with expression of the r-y2 w ithin the 293 cells 
but complete absence of its d eposi tion into the extracellular matri.x. 
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Figure 3. GB3 reacts only with the y2 chain as part of heterotri-
1 meric laminin- 5 in inuuunoblotting. A, c01 n parativc imn1unoblorting 
under non-reducing conditions. Each sample was boiled in SDS sample 
buffer without 2-mercaptoethanol. T he conditioned medium fi·actions of 
293 cells {ln11 es I , -1, n11d 7). pCPSy2-transfected 293 cells (ln11es 2 . 5. n11d 8) , 
and SCC-25 cell s {la11es 3, 6, n11d 9) were separated on a 5'X, acrylamide ge l 
and transferred to nylon membranes . T he medium of SCC-25 ce ll s was 
concentrated by Centricon-·t 00 (Amicon). The membranes were treated 
) with the fo llowing antibodies as the primary antibodies: GU3 {ln11cs I, 2, m11/ 
3, 1:50 dilution), anti-y2 antibody (h111ts 4, 5, n11d 6, 1:3000 dilu tion) and 
anti-laminin-5 antibody (/mil'S 7, 8, "'"' 9, I :250 di lu tion), and deve loped by 
ECL Western Blotting detection reagents (Amersham). B, comparative 
immunoblotting under reducing condi tions. Identica l samples as Fig 3A 
were treated identically except for the reduction of disu lfide bonds by 
/ 2-mercaptocthan o l. 
~ 
In contrast, GB3 did not show specific staining in the r-y2 express-
ing 293 cells (Fig 4E) . 
DISCUSSION 
In these studies we have shown that a monoclonal antibody, GB3, 
used in the diagnosis of the H e rli tz va riety of junctional e pide rma l-
' ysis bullosa (HJEB) recognizes an epitope that ex ists w ithin a 
specific chain (y2) of the laminin-5 heterotrimer. O ur add itio nal 
' characterization of th e epitope recognized by GB3 is impo rtan t in 
rhe interpretation of immunochemi cal data o bta in ed using GB3 o n 
JEB patient samples . GB3 and anti-y2 antibodies were compared 
for their abilities to precipitate the compl ete lami nin-5 fi·om the 
culture medium of SCC-25 cells and r-y2 fi·om cell s transfected 
with a y2 expression vector. In immunodepletion <:xperiments, 
' each antibody precipitated the same prowin recogn ized by the 
other antibody. Beca use M oA b GB3 reacted o nly with unredu ced 
hetero trimeric laminin-5 o n immunoblotting. but not the si ngle 
• r-y2 c h ain , we specul ate that in the absence of all three chains the 
r-y2 may have undergone a confo rm ation al change and lost 
reac tivity to GB3. To in ves tigate th is poss ibili ty further we con-
ducted immunoflu o rescent staining using GI33 . Altho ugh GB3 
1 reacted w ith m atrix deposited o n tissue culture plastic from cu l-
tured SCC- 25 cells, illustrating GB3 recognitio n of the laminin-5 
hetero trimer secre ted and layed down in the m atrix . even the 
cytoplasm of pCPSy2-transfected 293 ce lls, which contained the 
non-secreted r-y2, as shown by immunoflu o rescence of the cyto-
plasm using anti - y2 antibodies, did not sta in with GB3. Both of 
these resu lts are consistent with the idea that the epitope of GB3 is 
contained within the y2 chain but is unstab le w hen y2 cannot 
assemble with the o ther chains into the he terotrimer. 
pCPSy2-transfected 293 ce ll cultures did not show the depositio n 
of extracellular r-y2 by indirect immun ofl uo rescence using an ti-y2 
antibo dies. It is of potential impo rtance in interpreting this exper-
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Fig ure 4. GB3 reacts only with extracellular y2 chain as part of 
hcterotrintcric lantinin-5 in indirect intntunostaining. Indi rect inl -
munoA uorescent sta ining with MoAb Gl33 and the polyclonal anti-y2 
antiserum on 293 cell s (A,B), SCC-25 cell s (C. D) and r-y2 expressing 293 
cells (E,I--) . A and B. both antisera show no specific sta ining in 293 ce lls. C. 
Gl33 stains cxtracellularly and at the trail ing edge of migrating SCC-25 cell s. 
with n o in tracc llu ln r sta inin g:. D, anci-y2 antiscrun1 sta ins SCC-25 ce lls 
extrace llularl y as well. bm also shows granular cytoplasmic staining. E. GB3 
shows no reactivity with r-y2 expressing 293 ce lls. F. anti-y2 antibody gives 
gn.mular cytop lastnic stain in g in t·-y2 express in g 293 ce ll s. Bar, 20 }-tl11. 
ime n t that rat pheochromocytoma PC12 cells, w hich syn thes ize 
laminin-1 y1 prote in on ly, cannot fo rm y1 protein-con ta ining 
extracellular matrix [22]. It is possibl e that laminin-5 y2 protein 
also might require rhe othe r components for formation of a stable 
extrace llul ar matrix network. 
C linica lly, MoAb GB3 has proved to be useful for accurate 
identi ficatio n of HJEB patients, because this antibody reacts 
weakly, o r not at all , with HJEB skin (23) . It appears that in the 
HJEB patients thus fa r exa mined, the impaired expressio n of 
laminin-5 is a consequence of defective synthes is of o ne of its subunits 
(o:3 , {33, or y2), and thus the disease is genetically heterogeneous 
(24). We antic ipate that our an ti-y2 antisera would not give the 
same immunoh istologic sta ining resul ts as GB3 in all cases of HJEB 
patient skin. Alth o ugh both antibodies recognize the y2 chain 
specifi ca lly, destabiliza tion of the heterotrim er, even due to defec ts 
in the o:3 or {33 chains, may obscure the epitope recognized by GB3 
leading to absen t sta ining, whereas our anti-y2 antibody wou ld 
yie ld a n egative result on ly w hen the y2 chain is defective . 
Other useful MoAb preparations besides GB3, n oteably 19-
DEJ -1 , have bee n deve loped to aid in the diagn osis of EB . 
19- DEJ-1 recognizes a structure directly below the hemidesm o-
som e, perhaps associated w ith anchori ng filaments , that is com-
ple te ly miss ing in all J EB patien t skin and in 50'X, o f recessive 
dystroph ic EB patients as well [25,26). T he nature of the an tigen for 
19-DEJ is currentl y unde r investigation . 
We are entering a new era of diagnosis and treatm en t of EB 
based upo n recen t advances in DNA techn o logy. D iagnosis at the 
m o lecular level can be p rov ided by mutation identification of the 
defective gene; yet, immun o logic rea gen ts that detect gene defects 
at the protein level w ill retain some of the ir preeminen ce. Firstly, 
f.1cili ties for the ide n tification of DNA mutatio ns are still sufficiently 
complex to m ake the m largely unavailable to m ost clinicians ca lled 
upo n to make an ED diagnos is, w hereas immuno histo logy is m o re 
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access ible (using GB3 or other antibody reagents) . Secondly, 
de termination of the exact genetic lesion is grea tly facilitated by 
knowing which gene is defe ctive be fore beginning the search for 
mutatio ns. Detectio n of the final product of gene expression in 
patient cells, the expressed proteins, can be used as an informative 
screening procedure to direct mutation identifica tion e fforts using 
DNA teclmology. For these reasons further characterizations of 
c urrent immuno logic reagents used in EB diagnosis, such as GB3, 
rem ain important, as does the development of ne w chain-specific 
an tibodies, such as the y2 chain-specifi c antisera repo rted here . A 
battery of chain-specific antisera for laminin-5 may provide th e 
m ost re liab le protein diagnostic m ethod for the detection ofHJ EB. 
In fact, the genes for other components of the hemidesm osome, 
in cl udin g the 180- k.Da bul.l o us pemphigoid antigen [27] and the 
cx6f34 integr:in [28] have also been shown to contain genetic lesio ns 
that m ay ca use atrophi c benign JEB and J EB with pylo ric atresia, 
respectively. Ultimately, antibodies agai nst all hemidesm osoma l 
compo nents may be necessary to distinguish between the vari ous 
types of JEB. 
We "'""ld like to th a11k Dr. Peter Ma rill ko11ich, 111ho provided tlllti-/alllillill -5 
polyclollal a11tibody, a11d Pm11 Bemstei11 for secretarial assistn11cc. CM is partially 
S11pJ1011ed by the Uehara 111 e111 0ria/ fo111ulatio11 . 
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